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Abstract
Infantile neuronal ceroid lipofuscinosis (INCL) is a lysosomal storage disease that
is debilitating and fatal to children before their teenage years. The palmitoyl protein
thioesterase 1 (PPT1) knockout (Ppt1-/-) mouse is an appropriate animal model that
mimics much of the symptomology and brain pathology of the human disease. Ppt1-/mice display blindness, seizures, and motor deficits and die well before wild-type mice.
However, little is known about the cognitive and behavioral abilities of the Ppt1-/mouse.
This study was conducted to examine further the behavioral phenotype of the
Ppt1-/- mouse model of INCL by evaluating the animals’ abilities in such domains as
learning and memory, sensorimotor/motor coordination, and vision. To evaluate when
behavioral symptoms become detectable, two ages of mice were included in the study.
One cohort was tested beginning in the juvenile period (27 days old), and another cohort
was tested beginning in adulthood (147 days old).
Young Ppt1-/- mice showed no deficits in locomotor behavior, learning and
memory, or vision compared to WT mice. However, Ppt1-/- juveniles may experience
slight deficits in sensorimotor ability and motor coordination as indicated by decreased
distance traveled in the running wheel test and slower swimming speeds during the
Morris Water Maze. Adult Ppt1-/- mice exhibited more robust performance deficits,
including decreased locomotor activity, worse performance during Morris Water Maze
cued trials, decreased running wheel ability, and altered reactivity to fear conditioning.
These older animals appeared to maintain normal vision and spatial learning ability.
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The results of this study expand our knowledge of the Ppt1-/- mouse model of
INCL and provide novel information about the age of onset of behavioral symptoms.
While the adult Ppt1-/- mice showed extensive behavioral deficits, some disease
symptomatology was present even in the younger cohort. These results provide the
grounds for examining Ppt1-/- mice at various ages on various domains, with the purpose
of establishing solid behavioral markers to serve as benchmarks for disease progression
and treatment efficacy.
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Introduction
Lysosomal storage diseases (LSDs) are a group of more than 40 distinct disorders
characterized by abnormal intracellular storage of undegraded substrates. The function of
the lysosome is to convert unwanted intracellular substances into usable ones through
enzymatic metabolism. Lysosomal storage diseases are the results of defective lysosomal
function, often due to the reduced presence or efficacy of a specific enzyme. The
neuronal ceroid lipofuscinoses (NCLs) are a group of at least eight distinct disorders that
comprise a subset of LSDs typified by intracellular accumulation of autofluorescent
(light-emitting) storage material (ceroid lipofuscins) throughout the brain and body.
Individual NCLs are defined first by the age at onset of symptoms, and then by the
mutated gene associated with the disorder. Adult-onset NCL (ANCL) is the most variant
of the forms, with an age of onset ranging from 15-50 years and the mutation of one of a
number of responsible genes. Juvenile NCL (JNCL) patients first present symptoms
between 4 and 10 years of age and suffer from a mutation of the Cln3 gene. Late infantile
NCL (LINCL) is associated with mutations of the Cln2, Cln5, Cln6, Cln7, or Cln8 gene
and usually presents between 2 and 4 years of age. The most rapidly progressive of the
NCL subtypes is infantile neuronal ceroid lipofuscionosis (INCL), with patients first
showing symptoms between 6 months and 2 years of age. This condition occurs at a rate
of approximately 1 per 10,000-12,500 births worldwide. (Galvin et al., 2008; Miao et al.,
2009; Munasinghe, Zhang, Kong, Heffer, & Mukherjee, 2012; Shacka, 2012).
Infantile NCL is associated with an autosomal recessive mutation in the Cln1
gene which encodes for palmitoyl-protein thioesterase-1 (PPT1), a lysosomal enzyme
responsible for breaking long-chain fatty acids from proteins (Cooper, 2003). When this
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gene is mutated such that DNA translation and transcription for the protein is disrupted, a
deficiency in PPT1 occurs. Undegraded storage material begins to accumulate in many
cell types throughout the body, including in the central nervous system (CNS). This
storage material is made up of granular osmiophilic deposits, or GRODs, and its
accumulation accompanies the progression of behavioral symptoms experienced by
patients with INCL. Interestingly, while the NCLs are neurodegenerative in nature, there
is no evidence for a direct link between GRODs and subsequent cell death (Mitchison,
Ming, & Cooper, 2004). Still, the two occur simultaneously throughout disease
progression, and it is clear that cell death in the CNS results in INCL symptomology.
Although GROD accumulation occurs in virtually all cell types throughout the body, it is
assumed that the effects of the disease are confined to the CNS, although functional
significance of peripheral cell damage may not be apparent due to patients’ shortened life
spans (Galvin et al., 2008; Mitchison et al., 2004).
Patients with INCL appear unaffected at birth and show normal CNS
development until the age of 6-12 months. By 1 to 1.5 years, they exhibit a progression of
symptoms including visual loss to the point of blindness as well as motor deficiencies.
Untreatable seizures appear between 16 and 24 months, and death occurs as early as 6
years, although some live into their teenage years (Macauley et al., 2009). The dearth of
literature on cognition and behavior in humans with INCL is likely due to this shortened
lifespan and early mental deterioration. In many cases, patients fall into a coma between
3 and 4 years of age after having suffered rapid declines in speech and coordination and
an increase in irritability (Gupta et al., 2001; Miao et al., 2009). At such a young age with
serious decrement in overall ability, there are few tests that can be administered to
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measure cognitive capacity in these children. It is difficult, then, to speculate on the
abilities of these children in specific behavioral and cognitive domains.
INCL is invariably fatal in humans, and there is currently no treatment available
for the disease (Roberts et al., 2012). Cranial magnetic resonance imaging (MRI) of
patients with INCL reveals severe atrophy in the cerebral hemispheres and less severe
atrophy in the cerebellum (Kamate & Hattiholi, 2012). These images reveal that cerebral
white matter, basal ganglia and, especially, the thalamus show compromised tissue
integrity. Neuronal loss is profound in both the cerebral cortex and subcortical structures
and is accompanied by astrogliosis, microglial activation (a consistent marker of brain
injury and disease), and macrophage infiltration. At autopsy, the cerebellum shows loss
of both Purkinje and granule cells, and demyelination is evident throughout white matter
(Macauley et al., 2009).
In recent years an appropriate animal model of INCL has been developed by
creating a PPT1-knockout mouse (Ppt1-/-) (Gupta et al., 2001). These mice show a
disruption of the PPT1 enzyme and exhibit progressive motor abnormalities, myoclonic
seizures, and shortened life spans, a phenotype similar to human INCL, although at older
ages relative to the human ontogeny (Cooper, 2003). Additionally, this animal model
recapitulates the GROD accumulation, microglial activation, loss of gammaaminobutyric acid (GABA) neurons, apoptosis, astrocytosis, and cortical atrophy seen in
the human condition (Galvin et al., 2008). The mice mimic human INCL pathology and
exhibit a behavioral phenotype typical of the disease.
Mice show normal CNS development at a young age until about 2 months, which
in rodents is the human equivalent of late adolescence and young adulthood. Then, the
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mice begin to show a progression of symptoms including retinal dysfunction and
accompanying loss of vision, loss of motor coordination, development of seizures, and
premature death (Shacka, 2012). Retinal dysfunction progresses in severity such that, by
7 months of age, 60% of rod and cone function is lost (Griffey, Macauley, Ogilvie, &
Sands, 2005). Deficits in motor coordination, as measured by rotarod performance, are
evident, first, at 5 months and are severe by 7 months of age (Griffey et al., 2006;
Macauley et al., 2009). Myoclonic jerks are present beginning at 3-4 months and are
mostly brief upper body contractions that halt forward progress, appearing similar to a
violent sneeze (Gupta et al., 2001). Full-blown, “popcorn-like” seizures, wherein the
animals’ limbs propel their rigid bodies into the air repeatedly for up to a min at a time,
occur with increasing frequency beginning between 6.5 and 7 months of age and affects
all animals 7.5 months and older (Galvin et al., 2008). Untreated Ppt1-/- mice invariably
die before reaching 10 months, often living only to 8 months of age, considered
approximately “middle-age” for rodents. (Gupta et al., 2001; Macauley et al., 2012).
Sufficient research has accrued to confirm this knockout mouse as a useful animal
model for human INCL. It is currently the standard murine model upon which treatments
are evaluated. However, much remains unknown regarding the Ppt1-/- mouse, not the
least of which is a more complete behavioral profile beyond simply motor abilities. We
know that the mice exhibit blindness, seizures, and altered rotarod performance as adults,
beginning as early as 5 months, but other motor abilities and potential cognitive
abnormalities at the same age are unknowns.
Other questions include what is the behavioral phenotype of this animal model
during the juvenile and young adult stages? The Ppt1-/- mouse recapitulates many facets
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of human INCL, but these mice experience symptoms at ages that are not analogous to
the human condition. While humans with INCL do not live into their teens, Ppt1-/- mice
live well into adulthood, and the current literature suggests that they may not experience
symptoms until they reach full maturity at about 60 days old. This model provides us a
unique window of opportunity to examine behavioral consequences of the condition. Are
there cognitive or motor abnormalities that are detectable at a younger age? Recent
pathological findings provide a basis for exploring these research questions.
Galvin et al. (2008) investigated areas of GROD accumulation over the short
lifespan of the Ppt1-/- mouse and found small- to moderate-sized storage deposits in
cortical neurons, hippocampal neurons, and cerebellar Purkinje cells as early as 1 month.
These cell-types showed progressive fat and protein build-up, called lipopigment,
accumulating through 7 months of age at which point the deposits were described as
frequent and large-sized. By 3 months of age, GROD accumulation was significant in
glial and endothelial cells. Neuronal loss and resulting astrocytosis were apparent in the
CNS at 5 months, affecting the cerebral neocortex and hippocampal pyramidal cells. In
addition to these areas, astrocytosis was present in the cerebral and cerebellar white
matter beginning at 5 months (Galvin et al., 2008). Kielar et al. (2009) discovered
synaptic and axonal pathology in the Ppt1-/- thalamus as early as 3 months that
progressively worsened as the animal aged (Kielar et al., 2009). The same lab described
in detail the neuropathology of this mouse with regard to specific thalamic nuclei and
cortical regions. As young as 3 months of age, Ppt1-/- mice show increased lysosomal
storage material in the somatosensory cortex (S1) and thalamus as well as significant
astrocytosis in S1 and primary motor cortex (M1).
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Thalamic regions displaying astrocytosis at 3 months of age included the central
posterior, dorsal lateral geniculate, mediodorsal, central medial, and reticular thalamic
nuclei. Astrocytosis spread throughout the thalamus as the animals aged, but the
aforementioned nuclei showed it most often. Microglial activation, a marker of
neuroinflammation and neurodegeneration, was scattered across gray matter at 5 months
of age but showed a significant presence specifically in M1, primary visual cortex (V1),
S1, and various thalamic nuclei (Kielar et al., 2007).
The neuroanatomical studies, when considered alongside the existing research
documenting motor behavior abnormalities in late stages of the disease, lead back to the
fundamental questions for the Ppt1-/- mouse model of INCL. First and foremost, does the
specific damage to the brains of young mutant mice lead to behaviors characteristic of
INCL symptomatology? More specifically, given the areas of neuropathology and
neurodegeneration from 5 months onward, do mice exhibit motor deficits beyond the
rotarod, the standard behavioral test for this model? Also, given the various brain regions
and nuclei affected at this age, what are the cognitive abilities of Ppt1-/- animals? Does
brain pathology at 5 months and older translate to an abnormal behavioral phenotype
beyond just the rotarod test? If so, how early are these symptoms detectable? It is also
clear that parts of the brain show disease pathology as early as 1 month of age. The
question is, does this damage in the brains of young mutant mice lead to motor or
cognitive INCL symptomatology?
These are all questions that have yet to be addressed in the literature. The answers
would help complete the profile of this animal model and provide useful behavioral
benchmarks for disease progression and treatment efficacy. In this study, I sought to
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answer these questions and, perhaps, uncover novel behavioral markers in the Ppt1-/animal model of human INCL.
Materials and Methods
Animals
The method for developing PPT1-deficient mice is described in detail elsewhere
(Gupta et al., 2001). Briefly, the strain was created through a targeted disruption strategy
that eliminates the last exon of the murine PPT1 gene. This targeted mutation was
backcrossed to C57BL/6 mice for at least 10 generations. Animals for the experiment
were obtained from breeding pairs of mutant/mutant mice, and wild-type (WT) came
from a colony of pedigreed C57BL/6 mice maintained by Dr. Mark Sands. The genotype
of each animal was be determined by a three primer PCR assay explained in detail
previously (Gupta et al., 2001). Male and female mice of each genotype (N=45 for each
genotype) served as subjects in the experiment. Each gender was represented in each
genotype. All animals were housed in an animal facility at the Washington University
School of Medicine (St. Louis, MO) under a 12 h light/dark cycle with lights on at 06:00
and off at 18:00 and were provided food and water ad libitum. Behavioral tests were
conducted during the light-on part of the day. Animal procedures were approved by the
Institutional Animal Care and Use Committee at Washington University and were in
accordance with the guidelines of the National Institutes of Health.
Experimental Design
A cross-sectional design was used which involved two cohorts of Ppt1-/- and WT
mice and a total of N = 52 mice. In one cohort (n = 27) behavioral testing was initiated at
a mean age of post-natal day (PND) 27, and testing continued through PND 65. Although
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testing occurred up until early adulthood, this cohort will be referred to as the “juvenile”
cohort for the sake of convenience. In the juvenile cohort, the sample size for the Ppt1-/group was n = 16 (4 females; 12 males), while for the WT mice it was n = 11, (6 females,
5 males). In a second cohort of mice, behavioral testing began at PND 147 and continued
through to PND 185. In this second, adult cohort, the sample sizes were n = 14 for the
Ppt1-/- group (5 females; 9 males) and n = 11 for the WT control mice (7 females; 4
males). The mice were euthanized at the end of testing for each cohort.

Mean Age at Testing (postnatal days; PND)
Behavioral Tests

Cohort 1

Cohort 2

1 hr Locomotor Activity

PND 27

PND 147

Sensorimotor Battery

PND 28-29

PND 148-149

Morris Water Maze

PND 30-38

PND 150-158

PND39, 43, and 47

PND 159, 163, and 167

Visual Acuity

PND 40-42

PND 160-162

Actometer

PND44-46

PND164-166

Normal Running Wheel

PND 48-52

PND 168-172

Complex Running Wheel

PND 53-62

PND 173-182

Conditioned Fear

PND 63-65

PND 183-185

Rotarod

Table 1. Mean age of the cohorts for each behavioral test is shown.

Behavioral Testing
1-hr locomotor activity. To examine general activity levels and possible
differences in emotionality, mice were evaluated over a 1-hr period in transparent
polystyrene enclosures measuring 47.6 x 25.4 x 20.6 cm high. This testing has been
described previously (Wozniak et al., 2004). Each enclosure was surrounded by pairs of
photobeams which were monitored by computer software (MotorMonitor, Kinder
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Scientific LLC, Poway, CA). General activity variables included total ambulations,
rearing count, and time spent resting. Emotionality measures included time spent in,
distance travelled in, and number of entries into both a 33 x 11 cm central zone and the
surrounding peripheral area.
Sensorimotor battery. To evaluate possible effects of PPT1-deficiency on
balance, strength, and coordination, mice were assessed on a battery of sensorimotor tests
including walking initiation, ledge, platform, pole, 60° and 90° inclined screens, and
inverted screen. All tests have been described previously (Wozniak et al., 2004). Mice
were tested twice on each apparatus, and a mean of the two scores was used for analysis.
Walking initiation. Each mouse was placed in the middle of a square outlined
with white tape measuring 21 x 21 cm on a smooth surface. The time it took each mouse
to leave the square (all four paws outside of the tape) was recorded with a maximum time
of 60 s.
Ledge test. Each mouse was timed for how long it remained on a 0.75 cm
Plexiglas ledge without falling off with a maximum time of 60 sec.
Platform test. Each mouse was timed for how long it remained on an elevated
circular platform (3.0 cm in diameter, 47 cm off the floor). Animals received a maximum
score of 60 sec if they remained on the platform for the entire trial or if they successfully
climbed down the pole supporting the platform without falling in less than 60 sec.
Pole test. Each mouse was placed head upward on top of a vertical metal rod with
a finely textured surface (8 cm diameter, 55 cm height). The animals were tested for two
behaviors: how long it took to completely invert their bodies 180°, and how long it took
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to climb down the pole without falling. A maximum score of 120 sec was given if the
animal fell before reaching the floor or if it remained on the pole for the entire trial.
60° and 90° inclined screen and inverted screen tests. For the inclined screen
tests, mice were placed, head oriented toward the floor, in the middle of a wire mesh grid
(0.5 cm squares) tilted at either 60 or 90 degrees. The time it took the animal to climb to
the top of the screen was recorded, as well as the time the animal remained on the screen
with a maximum score of 60 sec. If the animal successfully climbed to the top of the
screen, a maximum score of 60 sec was recorded for the amount of time the animal
remained on the screen. For the inverted screen, the animal was placed as described
above and the screen was inverted. Time remaining on the screen was recorded with a
maximum score of 60 sec.
Morris water maze. To evaluate spatial learning and memory, mice were
evaluated on three different Morris water navigation trials (Morris, 1984). The protocol
included cued, place, and probe trials. Testing took place in a round pool (118 cm
diameter) containing water made opaque with non-toxic white tempura paint. All trials
were monitored through a live video feed by computer software (Any-maze, Stoelting
Co., Wood Dale, IL) which calculated swim speed, escape path length, escape latency,
and time and distance spent in each of the four quadrants of the pool. The maximum
score for all water maze trials was 60 sec.
Cued trials were conducted first to evaluate nonassociative learning factors such
as sensorimotor ability and motivational disturbances. Mice received 4 cued trials per day
for a total of 4 days in a room with very few items on the walls and ceiling so as to limit
spatial learning. On days 1 and 2, animals were placed in the water directly opposite a
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submerged platform marked with a visible pole and red tennis ball. In order to limit
spatial learning in the cued condition, the platform was moved to a different location for
each trial within the day and no extra-maze cues were placed on the walls or ceiling.
After each trial, mice were allowed to remain on the platform for 30 sec. Intertrial
intervals (ITIs) were approximately 45 min. During days 3 and 4 of cued trials, mice
were placed in the water directly opposite the submerged platform marked with only the
visible pole; the tennis ball having been removed. Again, the platform was moved to a
different location for each trial within the day, and ITIs were approximately 45 min.
Place trials took place the day after the final cued trials. In the presence of salient
distal cues to facilitate spatial learning, mice were evaluated on their ability to learn the
location of a submerged, unmarked platform. Large geometric shapes (a plus sign, a
triangle, a circle) cut from black poster board served as cues and were placed on the
white walls surrounding the maze. Cues remained in the same configuration on the walls
for the entirety of place (and probe) trials. Four place trials per day were administered for
5 consecutive days during which the platform remained in the same location with the
mice being released at 4 different locations per day. The daily protocol was to administer
2 sets of 2 trials each, with sets separated by approximately 1 hr.
A single probe trial was administered approximately 1 hr after completion of
place trials on the fifth day to evaluate retention of the platform location. During the
probe trial, the platform was removed from the pool and the animals placed in the
quadrant directly opposite the former platform location. Mice were allowed to explore the
water maze for 60 sec during which swim speed, path length, time spent and distance
travelled in each quadrant, and platform crossings were recorded.
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Rotarod. The rotarod test (Economex, Columbus Instruments, Columbus, OH)
was administered to evaluate motor coordination and balance. The protocol was similar
to one described previously (Ho et al., 2000) and involved three conditions: stationary
rod (60 sec maximum), constant rotation (2.5 rotations per min, 60 sec maximum), and
accelerating rotation (2.5-10.5rotations per min, 180 sec maximum). Trials were
administered on 3 test days, each separated by 4 days in an attempt to minimize
confounding with motor learning. Each test day included, in the following order, one
stationary trial, two constant trials, and two accelerating trials with trials separated by
approximately 30 min. Time spent on the rod for each trial was recorded.
Visual acuity. Mice were evaluated for visual acuity using the Virtual Optomotor
System (VOS) as described previously (Brown et al., 2010; Prusky, Alam, Beekman, &
Douglas, 2004). Briefly, the apparatus consists of a virtual cylinder comprising a vertical
sine wave grating projected in three-dimensional (3-D) space on computer monitors. The
4 monitors are arranged in a quadrangle around a central circular platform, forming a
square arena (46 cm x 46 cm). The floor of the arena is a square mirror and the ceiling is
the same but with a large central access hole. A camera (FireWire iSight; Apple
Computer Corp., Mountain View, CA, USA) is positioned directly above the platform to
allow visual access to the mouse’s behavior. After a mouse was placed on the central
platform, light and dark bars were projected on the monitors to give the appearance of a
cylinder rotating around the mouse. The virtual rotational motion of these bars induced
optokinetic head/body tracking movements. Thresholds for visuospatial acuity were
generated by increasing the frequency of the sine waves until the optokinetic response
was no longer observed, indicating that the animal no longer distinguished the individual
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lines rotating around them. An observer without knowledge of the direction of grating
rotation judged the presence or absence of head/body tracking movements by watching
live video of the mouse on a computer screen. The speed of rotation and geometry of the
projected cylinder was controlled by the system software. The dependent variable was the
highest grating (in cycles per degree; cyc/deg) at which the animal could discriminate
between light and dark rotating lines before failing to display optokinetic responses. All
testing was conducted under photopic conditions (1.8 log cd/m2).
Actometer. To assess exploratory behavior and gait, each animal was tested in
the force plate actometer. The design and detailed description of the actometer is similar
to a previous description but on a slightly larger scale (S. C. Fowler et al., 2001). Briefly,
a square load plate (42 x 42 cm) sits atop 4 load cell transducers (Honeywell/Sensotec,
Columbus, OH) and is surrounded by 4 Plexiglas walls measuring 43 x 30.5 cm. The
apparatus quantifies the movements of the animal within the chamber by measuring the
displacement of the center of force or center of pressures along the plate bottom.
Information from the 4 transducers is sent through the LabMaster (Scientific Solutions,
Mentor, OH) which converts analogue signals to digital form which can then be
processed through data acquisition software. To reduce outside movement, the chamber
is set atop a large slate slab (90 x 55.7 x 3 cm) that is stabilized by 4 rubber legs. The
animals were placed in the center of the chamber and allowed to explore for 20 min.
Dependent variables included distance travelled, low mobility bouts (times during which
the animal moved fewer than 15 mm in a span of 10 s), and gait analysis. For gait
analysis, for each 20-min recording session, a computer algorithm identified all episodes
of lateral movement on the actometer load plate that constituted ambulations or “runs”
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that covered a distance of 17.5 cm or more in a period of 1.5 s. In addition to providing
information on the mice’s capacities to sustain locomotion over a multi-body-length
distance, these runs were subjected to Fourier analysis as described previously (Fowler,
Miller, Gaither, Johnson, & Rebec, 2009). For a run to qualify for inclusion in the
analysis it had to have a nearly straight-line trajectory between its starting and ending
point. Dependent variables included stride length (in mm) and stride rate (in mm/s).
Normal and complex running wheel. Mice were evaluated for voluntary wheel
running activity as well as fine motor coordination between fore- and hindlimbs utilizing
a motor skill sequence (MOSS) protocol described previously (Maloney, Noguchi,
Wozniak, Fowler, & Farber, 2011).
Normal running wheel. Mice were tested on a normal mouse activity wheel
(Mouse Motor Skill Sequences Activity Wheel, Lafayette Instrument, Lafayette, IN) for 1
h on 5 consecutive days to establish baseline voluntary wheel running activity. Each
mouse was placed in a polycarbonate activity wheel chamber measuring 31.5 x 19.5 x
19.5 cm. The chamber floors were covered with a thin layer of bedding, and a
conventional aluminum running wheel was suspended from the chamber top. Running
wheel data was collected by an optical rotation sensor mounted 0.5 cm from the wheel
rungs and was transmitted to the Activity Wheel Monitoring System (Lafayette
Instrument, Lafayette, IN) on a nearby computer. The normal activity wheel contained 38
consecutive rungs (0.4 cm in diameter) that were spaced 0.614 cm apart. Mice were
allowed to explore the wheel and activity chamber for 1 h on 5 consecutive days.
Dependent variables were tracked by the software system and included average speed,
maximum speed, time spent running on the wheel (sum of 10 sec intervals in which the
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wheel rotated at least 6 times, converted to min), distance travelled (where 1 revolution of
the wheel equals 0.40 meters of distance travelled) and time spent resting (sum of 10 sec
intervals in which the wheel rotated 0 times, converted to min).
Complex running wheel. To assess fine motor coordination between the fore- and
hind-limbs, the mice were tested on the complex activity wheel. Spacing between wheel
rungs was made irregular by removing rungs to create gaps of 0.614, 1.6, or 2.6 cm. This
protocol allowed for more sensitivity in evaluating fine motor coordination than is
allowed by the normal activity wheel test (Maloney et al., 2011). Besides the
“customized” wheel, all other parameters of the apparatus remained the same as in the
normal activity wheel phase. Again, mice were allowed to explore the wheel and activity
chamber for 1 h each day, this time for 10 consecutive days. Dependent variables were
the same as those measured in the normal activity wheel.
Conditioned fear. The conditioned fear test was the final test administered
because of the emotional component involved and the possibility that this experience
could alter the animals’ reactivity to novel stimuli presented in subsequent testing. Mice
were evaluated for fear conditioning over 3 test days using a previously described
protocol (Wozniak, Xiao, Xu, Yamada, & Ornitz, 2007). Testing took place in two
Plexiglas conditioning chambers, each differing in terms of visual, tactile, and olfactory
cues. On the first day, mice were placed in the first Plexiglas chamber for one 5-min trial
during which freezing behavior was quantified by computer software (FreezeFrame,
Coulborn Instruments, Whitehall, PA). The first 2 min served as a baseline period, after
which an 80 dB tone (conditioned stimulus; CS) of white noise was presented for 20 sec.
During the last sec of CS, a 1.0 mA continuous foot shock (unconditioned stimulus; US)
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was administered. This pairing was repeated for each of the next 2 min. Twenty-four hr
later, each mouse was placed in the same chamber as the first day for an 8-min trial
during which no CS or US was presented. Again, freezing behavior was quantified, this
time as a measure of the hippocampal-related contextual fear conditioning. Twenty-four
hr after this trial, mice were evaluated on the auditory cue test. The animals were placed
in the other Plexiglas chamber and freezing behavior was quantified for 10 min in this
“altered context.” The first 2 min again served as a baseline period, followed by 8 min
during which the auditory tone (CS) was continuously presented. The dependent variable
for each trial was the percent of time the animal spent freezing. The FreezeFrame
software adjusts a freezing threshold for each animal and categorizes behavior as freezing
or not freezing during 0.75 sec intervals.
Statistical Analyses
All statistical analyses were conducted using PASW Statistics 18, Release
Version 18.0.0 (SPSS, Inc., 2009, Chicago, IL). Means and standard errors were
computed for each variable, and tables and figures are used to report findings. Analyses
included, where appropriate, factorial ANOVAs, including repeated measures ANOVAs
(rmANOVAs), and one-way ANOVAs. All ANOVA models contained Genotype as a
between-subjects variable. The rmANOVA models also typically contained either one
within-subjects variable (e.g., Blocks of Trials) or two within-subjects variables (e.g.,
trials and sessions). Sex was not included in the ANOVA models due to an unequal
distribution of sexes across groups. Simple main effects were calculated in the case of a
significant interaction. In the event of a violation of sphericity as measured by Mauchly’s
sphericity test, the F statistic, degrees of freedom, and p-value were all corrected via the
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Greenhouse-Geisser or Huynh-Feldt method in accordance with accepted guidelines
(Girden, 1992) For a significant F value for main and simple effects, pairwise
comparisons were used to compare means over the repeated measure. Probability value
for all analyses was p < .05, and multiple comparisons were Bonferroni adjusted.
Research Questions and Hypotheses
Research question 1: Do Ppt1-/- mice exhibit cognitive and motor deficits, compared
to wild-type mice, during adolescence: comparisons of Ppt1-/- and WT mice at 1-2
months of age.
The current study expanded the behavioral profile of the Ppt1-/- mouse by
employing a comprehensive battery of tests. The rotarod, a standard test for this animal
model, was used, along with other measures of motor ability and cognitive measures.
Since these animals had not yet been tested in many behavioral paradigms, it was
difficult to speculate how they would perform at any age, much less an age younger than
has been evaluated on any test. Still, the body of research detailing neuropathology at
various ages provided some clues. Hypotheses regarding behavioral testing at 1-2 months
of age included:
Hypothesis 1A: My hypothesis was that there would be no differences between
experimental and WT control groups on horizontal ambulations, vertical rears, or
time spent in center or peripheral zones of the activity chamber. This prediction
was based on informal observations in our lab and others.
Hypothesis 1B: The researchers who developed the mouse model of INCL noted a
“strongly abnormal clasping behavior” when the animal was suspended by its tail
as early as 50 days of age (Gupta et al., 2001). However, in my first cohort, mice
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were 3 weeks younger than those that displayed the abnormal clasping behavior.
Moreover, no changes in Purkinje cell numbers were observed in the cerebellum
at this age (Macauley et al., 2009). Although Purkinje cells show GROD
accumulation at this age, there may be no direct link between this accumulation
and behavioral disruptions (Galvin et al., 2008). Consequently, the hypothesis
was for no differences between groups on any of the sensorimotor tasks.
Hypothesis 1C: Since there is no detectable hippocampal pathology in the Ppt1-/- mouse
at this age, I expected no deficits in the Morris Water Maze. No differences
between groups were expected on latency to find the escape platform, distance
travelled to the platform, or average swim speed.
Hypothesis 1D: In accordance with previous findings (Macauley et al., 2009), Ppt1-/mice were expected to perform similarly to WT mice on the stationary and
constant rotarod conditions. On the accelerating rotarod, however, the hypothesis
was that the Ppt1-/- group would spend significantly less time balanced on the
apparatus. I expected significant changes over days of testing as the mutant
animals experience increased neuropathology in S1, M1, and various thalamic
nuclei.
Hypothesis 1E: Previous research has shown that untreated Ppt1-/- mice experience an
18% decrease in retinal function as early as 60 days of age (Griffey et al., 2005).
The animals in the current study were approximately 41 to 43 days old, and
therefore no differences were expected in visual acuity, measured by the highest
grating at which they could discriminate between light and dark rotating lines
before failing to display an optokinetic response, between the mutants and WTs.
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Hypothesis 1F: There would be no differences in measures of low mobility bouts or
distance traveled between Ppt1-/- and WT mice. Because mutants at this age
show increasing neuropathology in S1, M1, and various thalamic nuclei, the
hypothesis was that Ppt1-/- mice would have altered gaits as revealed by
abnormal foot-strike patterns on the force-plate actometer.
Hypothesis 1G: No differences were expected between groups on any of the variables
measured by the normal activity wheel test.
Hypothesis 1H: By the end of complex activity wheel testing, groups were approximately
63 days old. Pathology will have been nearing significance in various thalamic
nuclei as well as S1 and M1 areas. The complex activity wheel is a sensitive
measure of motor coordination and learning, and it was expected that Ppt1-/- mice
would show deficits. Specifically, mutants were expected to run a shorter
distance, run at a slower average speed and have a lower maximum speed than
WT mice. No differences were expected in time spent interacting with the wheel.
Hypothesis 1I: Although a different animal model of NCL (the mnd mouse with Cln8
mutation) than the one used here has shown deficits in fear conditioning possibly
associated with amygdalar neuropathology (Bolivar, Ganus, & Messer, 2002), no
differences were expected in time spent freezing on any of the conditioned fear
test days. Significant pathology in the amygdala-hippocampal circuit has not been
found in 1-2 month old Ppt1-/- mice.
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Research question 2: Do adult Ppt1-/- mice exhibit cognitive and/or motor deficits:
comparisons of experimental and wild type mice at 5-6 months of age.
Hypothesis 2A: Previous research with 7-month-old Ppt1-/- animals shows reduced
general exploratory behavior as measured by total horizontal ambulations.
Mutants also exhibited fewer entries into the central area of the activity chamber,
indicating increased anxiety-like behavior (Griffey et al., 2006). Because 5 month
and 7 month old Ppt1-/- mice show similar pathologies, similar results were
expected. Ppt1-/- were predicted to exhibit decreased horizontal ambulations,
vertical rears, and entries into the central zone, and time spent in the central zone
compared to WT controls.
Hypothesis 2B: It was revealed in the same study (Griffey et al., 2006) that Ppt1-/- mice
7 months of age showed increased time to climb down the pole and decreased
time balancing on the ledge, tests included in the sensorimotor battery in the
current study. This hypothesis was that similar differences would be found in
mutants at 5 months of age. Ppt1-/- mice were expected to show increased time to
leave the square, decreased time on the ledge, decreased time on the platform,
increased time to climb down the pole, increased time to climb to the top of the
60- and 90-degree screens, and decreased time hanging on the inverted screen
compared to control mice. No group differences were expected in time remaining
on the 60- and 90-degree screens.
Hypothesis 2C: Due to the motor deficits expected at this stage of life, as well as
emerging neuropathology in the hippocampus and decreased retinal function, it
was expected that Ppt1-/- animals would show deficits in the Morris Water Maze.

28

Specifically, mutants were predicted to take longer to find the platform, travel a
farther distance to the platform, and swim slower than controls during the cued
and place trials. During the probe trial, Ppt1-/- animals were expected to swim
slower than controls and would exhibit less time spent in the target quadrant as
well as fewer platform crossings.
Hypothesis 2D: In accordance with previous findings (Macauley et al., 2009; Roberts et
al., 2012), it was predicted that Ppt1-/- mice would spend less time on the rotarod
apparatus than WT controls during both the continuous and accelerating
conditions. No differences were expected between groups on the stationary trials.
Hypothesis 2E: With the significant decrease in retinal function at 5 months of age
(Griffey et al., 2005), this hypothesis was that mutants would exhibit decreased
visual acuity compared to WT control mice.
Hypothesis 2F: Mutants were expected to show more low mobility bouts, decreased
distance traveled, and an abnormal gait compared to controls.
Hypothesis 2G: It was expected that Ppt1-/- mice would show decreased levels of activity
in the normal running wheel as indicated by shorter distance, slower average
speed and slower maximum speed compared to WT mice. However, I
hypothesized that Ppt1-/- mice would spend a similar amount of time interacting
with the wheel as controls.
Hypothesis 2H: Similarly, 6 month old Ppt1-/- mice were predicted to travel a shorter
distance, run slower on average and have a slower maximum speed than WT
mice. Again, no group differences were expected in time spent interacting with
the wheel.
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Hypothesis 2I: Hippocampal pathology suggests that Ppt1-/- mice would show decreased
freezing activity compared with control mice on all 3 trials of the conditioned fear
test.
Results
1-h Locomotor Activity
Juveniles. To assess habituation and exploratory behaviors over the 1 hr testing
period, rmANOVAs were conducted on total ambulations and vertical rearing frequency
over six 10-min blocks with Genotype (Ppt1-/- versus WT) as the main factor and Time
Blocks as the within-subjects repeated measure. No significant main or interaction effects
involving Genotype were found for either total ambulations or rearing frequency. To
evaluate habituation, the performance on Block 1 versus Block 6 was evaluated within
each group for total ambulations and rearing frequency. The results of these comparisons
showed that Ppt1-/- mice exhibited significant decreases indicating habituation from
Block 1 compared to Block 6 for total ambulations, p = .000, and rearing frequency, p =
.000, while the WT group demonstrated the same effects, p = .000 for both. One-way
ANOVAs conducted on time spent in center zone, distance traveled in center zone,
entries made into center zone, distance traveled in peripheral zone, and total rest time did
not yield any significant main or interaction effects involving Genotype, indicating that
the two groups performed similarly on these variables (Figure 1A-F).
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Figure 1. Juvenile 1-h locomotor activity. Juvenile WT and Ppt1-/- mice performed similarly on all measures during the 1 h
locomotor activity test, including (A) total ambulations, and (B) total number of rears. Both groups showed habituation over
time, exhibiting fewer ambulations and rears during Time Block 6 compared to Time Block 1, *p = .000. WT and Ppt1-/- mice
also performed similarly on (C) distance traveled in the edge of the chamber, (D) entries into the center of the chamber, (E)
time spent in the center zone, and (F) distance traveled in the center zone.

Adults. In contrast to the juvenile results, ANOVAs conducted on the variables
from the 1 h activity test in the adult mice showed that groups differed on every
performance variable. Specifically, rmANOVAs conducted on the total ambulations and
rearing data produced significant main effects of Genotype for each variable,
F(1,23)=15.11, p=.001 and F(1,23)=5.10, p=.034, respectively, indicating that the WT
mice exhibited significantly increased levels for both variables over time (Figure 2A and
B). WT mice showed increased total ambulations, compared to Ppt1-/- mice, during Time
Blocks 3, 4, 5, and 6, p < .002 for all. Comparisons of performance during Block 1 versus
Block 6 demonstrated that the WT and Ppt1-/- groups each significantly decreased their
total ambulations, p = .000 for both, but not rearings, over the test session. Significant
Genotype effects were found following one-way ANOVAs conducted on each of the
remaining variables (Figure 2C-F). For example, WT mice traveled a farther distance in
both the peripheral and center zones, F(1,24)=6.95, p=.015 and F(1,24)=22.62, p=.000,
respectively, compared to the Ppt1-/- group. In addition, WT animals entered the center
zone more times than the Ppt1-/- animals and also spent more time in the center zone,
F(1,24)=26.63, p=.000 and F(1,24)=4.49, p=.045 respectively. Also, adult Ppt1-/- mice
spent more time resting during the 1 h test than the WT mice, F(1,24)=19.77, p=.000.
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Figure 2. Adult 1-h locomotor activity. Adult Ppt1-/- mice exhibited fewer (A) total ambulations, p = .001 and (B) fewer total
rears, p = .034, compared to WT mice during the 1 h locomotor activity test. Ppt1-/- mice also (C) traveled a shorter distance in
the edge of the chamber, p = .015, (D) entered the center zone fewer times, p = .000 (E) spent less time in the center zone, p =
.045 and (F) traveled a shorter distance in the center zone, p = .000, compared to WTs. ** Denotes a significant main effect of
Genotype across intervals. * Denotes a significant main effect of Genotype. ^ Denotes group differences at a single Time Block.

Sensorimotor Battery
Sensorimotor data were analyzed by a one-way ANOVA for each of the tests in
the battery, where Genotype (Ppt1-/- versus WT) served as the main factor and scores
averaged across two trials served as the dependent variables.
Juveniles. One-way ANOVAs revealed no effect of Genotype for the ledge,
platform, pole, 90° inclined screen, or inverted screen tests. However, Ppt1-/- mice
required significantly more time to move out of the square during the walking initiation
test compared to the WT group, F(1, 25)=5.86, p=.023. In addition, a significant
Genotype effect was found for the 60° inclined screen data, with Ppt1-/- mice taking
longer to climb to the top of the screen than their WT counterparts, F(1,25)=14.16,
p=.001, (Figure 3).
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Figure 3. Juvenile sensorimotor battery. Juvenile Ppt1-/- mice (A) required more time to leave the
walking initiation square, p = .023, and (C) more time to climb to the top of the 60° inclined screen, p =
.001, compared to WT mice. Genotypes performed similarly on the (B) ledge and (D) 90° inclined screen
test. * Denotes a significant main effect of Genotype.

Adults. One-way ANOVAs yielded significant Genotype effects for the ledge,
F(1,24)=7.70, p=.011, and the 90° inclined screen, F(1,24)=5.20, p=.032, tests showing
that Ppt1-/- mice spent less time balancing on the ledge and required more time to climb
to the top of the 90° screen compared to WT mice (Figure 4). There were no differences
between groups on any of the other sensorimotor measures.
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Figure 4. Adult sensorimotor battery. Adult Ppt1-/- mice performed similarly to WT mice on the (A)
walking initiation and (C) 60° inclined screen tests. However, Ppt1-/- mice (B) balanced on the ledge for
less time, p = .011, and (D) required more time to climb to the top of the 60° inclined screen, p = .032,
compared to WT mice. * Denotes a significant main effect of Genotype.

Morris Water Maze
For the MWM cued condition, trials were grouped into blocks consisting of 2
trials each, resulting in 8 total blocks. The data for each block was the mean score of
those two trials. The first 4 blocks were analyzed with a rmANOVA, with Genotype
(Ppt1-/- versus WT) as the main factor and Blocks of Trials as the repeated measure, to
assess cued learning when the platform was marked by both a pole and a ball. A second
rmANOVA was used to analyze the final 4 Blocks of Trials to assess the same behavior
when the platform was only marked by a thin pole. For the place condition, this same
blocking technique was applied but with blocks of 4 trials instead of 2. Again, data was
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analyzed with a rmANOVA with Genotype as the main factor with Blocks of Trials as
the repeated measure. Data from the single probe trial consisted of time spent in each of
the 4 pool quadrants (the target quadrant and each of the quadrants to the left, right, and
opposite the target) and number of entries into the platform zone. A one-way ANOVA
was performed separately for the number of platform entries and time spent in the target
quadrant, with Genotype serving as the main factor for both. Additionally, a rmANOVA
was used to compare the amount of time the animals spent in each of the 4 quadrants
during the probe trial
Juveniles. No significant main or interaction effects involving Genotype were
found for escape path length, latency, or swimming speeds during the first 4 Blocks of
Trials in the cued MWM (Figure 5A-C), thus documenting similar performances by the
WT and Ppt1-/- mice on these variables when the platform was marked by a visible pole
and ball. A significant effect of Blocks of Trials for latency, F(3, 75)=41.11, p=.000, and
path length, F(3, 75)=43.43, p=.000, plus significant differences from comparisons made
between the first and last block of trials within each group which showed significant
decreases in the levels of both variables, p = .000 for all, demonstrated significant
acquisition of cued learning in both groups.
However, when the platform was marked only by a visible pole, a main effect of
Genotype was found for both latency, F(1,25) = 4.39, p = .046, and swim speed, F(1,25)
= 4.89, p = .036, indicating that Ppt1-/- mice required more time to find the escape
platform and swam slower across blocks of trials compared to WT mice (Figure 5A-C).
A significant Genotype x Blocks of Trials interaction effect was found for swim speed,
F(3,75) = 4.320, p = .007, with pairwise comparisons indicating that while WT animals
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showed an increase in swim speed between the first and the last blocks of trials, p = .001,
Ppt1-/- mice did not. In addition, WT mice swam significantly faster than Ppt1-/- during
the final block of trials, p = .006. A significant effect of Blocks of Trials was revealed for
latency, F(3,75)=4.37, p=.007, path length, F(3,75)=3.56, p=.018, and swim speed,
F(3,75)=7.09, p=.000. Across genotypes, mice required less time (p = .005) and traveled
less distance (p = .006) to find the escape platform..
No significant main or interaction effects involving Genotype were found for path
length or latency during acquisition training in the place condition, indicating that the two
groups performed similarly concerning these two variables (Figure 6A and B). However,
there was a main effect of Genotype with regard to swimming speeds, F(1,25) = 6.36, p =
.018, indicating that the WT mice swam significantly faster, on average, than Ppt1-/mice during place trials (Figure 6C). Evidence that both groups displayed significant
place (spatial) learning was supported by a significant effect of Blocks of Trials for
latency, F(3.02, 75.57) = 14.70, p = .000, and path length, F(3.13, 78.30) = 18.96, p =
.000. Further evidence was provided by a significant decrease in Ppt1-/- latency (p =
.000) and path length (p = .000) as well as WT latency (p = .004) and path length (p =
.003) from trial block 1 to trial block 5. The two groups also performed similarly on the
retention variables during the probe trial. Specifically, no significant overall effects
involving Genotype were found for platform crossings, time spent in the target quadrant,
or spatial bias. Both groups showed spatial bias for the target quadrant, F(2.32, 57.90) =
59.86, p = .000, in that they spent significantly more time in the target quadrant compared
to the times spent in the quadrant to the right (p = .000), left (p = .000), and opposite (p =
.000) the target quadrant (Figure 7A and B).
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Figure 5. Morris Water Maze, cued trials. In the juvenile cohort (A-C), genotypes performed similarly on all variables when the platform was
visibly marked with a pole and tennis ball (Ball + Pole). When the ball was removed from the pole (Pole only), Ppt1-/- mice (B) required more time to
find the escape platform, p = .046, and (C) swam significantly slower than WT mice, p = .036. In the adult cohort, Ppt1-/- mice (D) required more
time to find the platform, p = .000, (E) swam a longer distance, p = .011 and (F) swam significantly slower than WTs, p = .000 during Ball + Pole
blocks of trials. During Pole only trial blocks, the differences in (D) path length, p = .006, (E) latency, p = .000, and (F) swim speed, p = .000,
persisted. * Denotes a significant main effect of Genotype. ^ Denotes group differences at a single trial block.

Adults. Multiple rmANOVAs on the data from the first 4 Blocks of Trials during
cued MWM produced a significant main effect of Genotype on latency, F(1, 23)=36.62,
p=.000, path length, F(1, 23)=7.56, p=.011, and swimming speeds, F(1, 23)=33.00,
p=.000, demonstrating that Ppt1-/- mice required more time, p = .000, swam a longer
distance, p = .000, and swam at a slower speed, p = .000, to find the escape platform
(Figure 5D-F). A significant effect of Blocks of Trials for latency, F(3, 69)=19.30,
p=.000, path length, F(3, 69)=20.22, p=.000, and swimming speeds, F(3, 69) = 3.18, p =
.029, as well as both Genotypes showing improvement on latency and path length from
trial block 1 to trial block 4, p = .000 for all, provide evidence of cued learning in both
groups.
During the second 4 Blocks of Trials, significant main effects of Genotype on
latency, F(1, 23)=12.07, p=.000, path length, F(1, 23)=8.97, p=.006, and swimming
speeds, F(1, 23)=23.88, p=.000 were found. Again, Ppt1-/- mice required more time, p =
.002, swam a longer distance, p = .006, and swam at a slower speed, p = .000, to find the
escape platform (Figure 5D-F). There was no main effect of Blocks of Trials on any of
the 3 variables, but a significant Genotype x Blocks of Trials interaction was found for
latency, F(2.54, 58.50) = 4.04, p = .015, as well as swimming speeds, F(3,69) = 11.53, p
= .000. Specifically, WT mice required less time to find the escape platform during trial
blocks 1, 2, and 3, p ≤ .010, but not block 4, compared to Ppt1-/- mice. Mutants swam
slower than WTs during blocks 1, 2, and 3, p = .000, but not block 4.
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Figure 6. Morris Water Maze, place trials. Juvenile groups performed similarly with regard to length (A) escape path and (B) latency during the
place trials. However, Ppt1-/- mice (C) showed significantly decreased swimming speeds averaged across blocks of trials (p = .018). No differences
were observed between the adult groups in terms of (D) path length, (E) latency, or (F) swimming speeds. *Denotes a significant main effect of
Genotype.

During place trials, rmANOVAs failed to produce any significant main or
interaction effects involving Genotype for escape path length, latency, or swimming
speeds (Figure 6D-F). A significant effect of Blocks of Trials for latency, F(4, 92)=5.22,
p=.001, and path length, F(4,92)=8.16, p=.000, followed by comparisons showing
significant decreases in the levels of both variables between the first and last block of
trials, documented spatial learning acquisition in both groups. No significant overall
effects involving Genotype were found concerning swimming speeds although all mice
swam significantly slower during block 5 compared to all other blocks, p < .001 for all
comparisons. The retention data from the probe trial measures were consistent with the
lack of differences during acquisition training in the place condition. Specifically, no
overall effects involving Genotype were found with regard to platform crossings or time
spent in the target quadrant. Each group showed spatial bias for the target quadrant by
spending significantly more time in it compared to the times spent in quadrant to the
right, p = .000, left, p = .000, and opposite the pool, p = .000 (Figure 7C and D).
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Figure 7. Morris Water Maze, probe trials. Juvenile Ppt1-/- and WT mice (A) showed significant spatial
bias for the target quadrant compared to each of the other three quadrants, although no differences were
observed between groups with regard to time spent in the target quadrant. In addition, Ppt1-/- mice (B)
exhibited a similar number of platform crossings during the probe trial. The same pattern of results was
found for the adult cohort (C and D). The dashed lines at 15 s in A and C indicate the time expected in each
quadrant based on chance alone. * Denotes a significant difference from each of the other quadrants, p ≤
.005.

Rotarod
The dependent variable for the rotarod test was time spent, in sec, on the rod for
each trial.
Juveniles. Analyses included a rmANOVA for stationary trials (1-3), with
Genotype (Ppt1-/- versus WT) as the main factor and Trial as the repeated measure.
Results indicated no effect of Genotype (data not shown). A 2 x 2 x 3 rmANOVA was
performed on time on the constant speed rotarod with Genotype as the between-subjects
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factor and test Session (1-3) and Trial (1 and 2) as the within-subjects repeated measures
(Figure 8A). No significant main or interaction effects involving Genotype were found.
There was a significant main effect of Session, as well as a significant Session-by-Trial
interaction, F(1.15, 28.69) = 5.01, p = .029 and F(1.12, 27.93) = 4.65, p = .036,
respectively. Mice performed better on the constant speed trials of session 2, p = .044,
and session 3, p = .024, than on constant speed trials of session 1. Within session 1,
animals performed better on trial 2 than on trial 1, p = .033.
Another 2 x 2 x 3 rmANOVA was performed on accelerating rotarod time with
Genotype as the between-subjects factor and test Session (1-3) and Trial (1 and 2) as the
within-subjects repeated measures (Figure 8B). Results indicated no effect of Genotype,
but a significant effect of Trial, F(1,25)=15.82, p=.001, and a Session x Trial x Genotype
interaction, F(2,50)=5.58, p=.007. In session 1, but not session 2 or 3, WT mice
performed better on trial 2 than on trial 1, p = .001. However, Ppt1-/- mice performed
better on trial 2 versus trial 1 only during session 3, and not session 1 or 2, p = .008.
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Figure 8. Constant speed and accelerating rotarod. WT and Ppt1-/- mice performed similarly on
constant speed and accelerating rotarod trials as both (A and B) juveniles and (C and D) adults.

Adults. Analyses revealed no main or interaction effects of Genotype on
stationary, constant speed, or accelerating rotarod trials (Figure 8C and D). During
constant speed rotarod trials, a main effect of Session was found, F(2,46) = 10.23, p =
.000, with all animals balancing longer on the rod in session 3 than session 1, p = .000,
and session 2, p = .004. All mice also performed differently over test sessions, F(2,46) =
23.52, p = .000, and between trials, F(1,23) = 6.64, p = .017, during accelerating rotarod
testing. Over sessions, animals remained on the rod significantly longer during trial 2
than trial 1; over trials, animals remained on the rod longer during session 3 than sessions
1 and 2, p = .000 and .001 respectively.
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Visual Acuity
Analyses for the visual acuity test included a one-way ANOVA to compare means
for each genotype (Ppt1-/- versus WT ) calculated for the highest grating (in cyc/deg) at
which the animals discriminated between light and dark rotating lines before failing to
display an optokinetic response.
Juveniles. Results indicated that Ppt1-/- mice displayed a higher threshold for
optokinetic response compared to WT mice, F(1,25)=5.72, p=.025 (Figure 9A).
Adults. In contrast to the younger cohort, adult WT and Ppt1-/- mice performed
similarly on this test of visual acuity (Figure 9B).

Figure 9. Visual Acuity. Juvenile Ppt1-/- (A) mice exhibited a greater visual acuity threshold compared to
WT mice, while the adult cohort (B) did not exhibit this difference. * Denotes a significant main effect of
Genotype, p = .025.

Actometer
Distance, low mobility bouts, stride length, and stride rate were analyzed using a
one-way ANOVA with genotype (Ppt1-/- versus WT) as the main factor. For gait
analysis, data was sent to Dr. Stephen Fowler at the University of Kansas, Department of
Pharmacology and Toxicology. His analyses included the Fourier transformations
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previously described (Fowler et al., 2009) to determine genotypic differences in force
plate power spectra.
Juveniles. A main effect of Genotype was found on distance traveled, F(1,26) =
6.53, p = .017, and stride rate, F(1, 25) = 8.95, p = .006, revealing that WT mice traveled
a significantly farther distance during the 20-min trial and took more strides per s during
long runs compared to Ppt1-/- mice (10B). There was no effect of Genotype on number
of low mobility bouts or stride length (10A).
Adults. There was no main effect of Genotype with regard to distance traveled or
low mobility bouts during the actometer test. However, analyses revealed a significant
Genotype effect on stride length, F(1,23) = 37.635, p = .000, showing that WT mice ran
around the test chamber using a longer stride length compared to Ppt1-/- mice (Figure
10C). In contrast to the juveniles, adult WT and Ppt1-/- mice ran at a similar number of
strides per s during the actometer trial (Figure 10D).
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Figure 10. Actometer. During the 20 min actometer session, juvenile Ppt1-/- and WT mice exhibited (A)
similar stride lengths, but (B) WT mice traveled at a higher stride rate. In the adult cohort, (C) Ppt1-/- mice
exhibited a shorter stride length but (D) stride rate did not differ between genotypes. * Denotes a significant
main effect of Genotype, p < .05.

Normal and Complex Running Wheel
Three separate rmANOVAs were used to analyze the running wheel d WT) as the
main factor and day (1-5) as the repeated measure. Dependent variables included average
speed, maximum speed, distance travelled, and time spent resting.
Juveniles. During baseline testing (week 1), analyses revealed a significant main
effect of Genotype on distance traveled, F(1,25)=7.00, p=.014, and time spent away from
the wheel (resting), F(1,25)=7.83, p=.010, with WT mice running farther (Figure 11A)
and spending less time resting (Figure 14A) compared to Ppt1-/- mice. There was no
main effect of Genotype on average speed (Figure 12A) or maximum speed (Figure
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13A). A main effect of Trial was found for distance traveled, F(3.26, 81.56)=73.47,
p=.000, average speed, 3.17, 60.18)=53.54, p=.000, and maximum speed, F(3.28,
82.02)=104.33, p=.000. For each of these measures, the value for trial 5 was significantly
higher than the value for trial 1, p = .000. No effect of Trial was found for time spent
resting, and all interactions were nonsignificant (data not shown).
Results for all variables during acquisition testing (week 2) reflect the differences
found during baseline testing. Again, analyses revealed a main effect of Genotype on
distance traveled, F(1,25)=4.32, p=.048 and time spent resting, F(1,25)=10.52, p=.003,
with WT mice running farther (Figure 11B) and spending less time resting (Figure 14B)
compared to mutants. No effect of Genotype was found for average speed (Figure 12B)
or maximum speed (13B). A significant effect of Trial was found for distance traveled,
F(3.28, 82.11)=66.55, p=.000, average speed, F(1.82, 45.25)=126.89, p=.000, and
maximum speed, F(2.05, 51.25)=59.29, p=.000, and comparisons of values between trial
1 and trial 5 indicated that all mice improved performance on these measures over trials,
p = .000.
Unlike results from the preceding 2 weeks of testing, no main effect of Genotype
was found for any of the running wheel variables during performance testing (week 3).
However, the rmANOVA revealed a significant Genotype x Trial interaction for distance
traveled, F(3.29, 82.29)=2.70, p=.046. Within-groups, the Ppt1-/- mice increased their
distance traveled from trial 1 to trial 5, a difference that the WTs did not exhibit. Pairwise
comparisons did not reveal differences between groups with regard to distance traveled
on any trial. A main effect of Trial was revealed for distance traveled, F(3.29,
82.29)=8.94, p=.000, average speed, F(3.19, 79.70)=10.51, p=.000, and time spent
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resting, F(4,100)=6.39, p=.000. Pairwise comparisons indicated that all mice increased
distance traveled (Figure 11C) and average speed from trial 1 to trial 5, p = .000 (Figure
12C), and all mice rested more during trial 1 than trial 5, p = .005 (Figure 14C).
Adults. During baseline testing, rmANOVAs revealed a main effect of Genotype
on distance traveled, F(1, 23)=44.44, p=.000, average speed, F(1, 16)=5.73, p=.029,
maximum speed, F(1, 23)=17.27, p=.000, and time resting, F(1, 23)=32.93, p=.000,
indicating that WT mice traveled a farther distance (Figure 11D) at a faster average speed
(Figure 12D) than Ppt1-/- mice. WT mice also ran at a higher maximum speed (Figure
13D) and spent less time resting compared to Ppt1-/- mice (Figure 14D). On each of
these measures, a significant effect of Trials was found. All mice ran farther, F(4,92) =
10.66, p = .000, during trial 5 than trial 1, p=.000. Average running speed differed over
trials, F(4,92) = 13.51, p = .000, with animals averaging a faster pace during trial 5 than
trial 1, p=.000. Maximum speed was also different over trials, F(4,92) = 20.85, p = .000,
with all animals reaching a higher maximum speed during trial 5 than during all other
trials, p < .002. Finally, animals spent more time at rest, F(4,92) = 3.95, p = .005, during
trial 2 compared to trial 1, p=.001, and trial 3, p=.005.
Main effects of Genotype on distance traveled, F(1, 23) = 30.89, p = .000,
average speed, F(1, 14) = 5.143, p = .040, maximum speed, F(1, 23) = 15.070, p = .001,
and time resting, F(1, 23) = 20.61, p = .000, were found again during acquisition testing.
WT mice exhibited higher values, compared to mutants, on distance (Figure 11E),
average speed (Figure 12E), and maximum speed (Figure 13E), while Ppt1-/- mice rested
for more time than WTs (Figure 14E). Results of rmANOVAs also revealed a significant
Genotype x Trial interaction for distance traveled, F(3.08, 70.92)=5.97, p=.001, and
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average speed, F(1.88, 26.23)=5.501, p=.011. WT mice traveled farther than Ppt1-/- mice
at every trial, p = .000. Within-groups, both Ppt1-/- and WT mice showed an increase in
distance traveled from trial 1 to trial 5, p < .001. Genotypes ran at similar average speeds
during every trial, but only WT mice exhibited an increase in average speed from trial 1
to trial 5, p = .000. Analyses revealed a significant effect of Trials on all of these
variables as well; distance traveled, F(3.08, 70.92) = 34.29, p=.000, average speed,
F(1.88, 26.32) = 28.77, p=.000, maximum speed, F(1.82, 41.85) = 39.10, p=.000, and
time resting, F(2.01, 46.23) = 3.50, p=.038, all differed over trials. Pairwise comparisons
revealed that all mice increased scores on distance traveled, average speed, and maximum
speed from trial 1 to trial 5, p = .000. For time resting, none of the pairwise comparisons
for trials was significant following Bonferroni correction.
The pattern of between-group differences was essentially repeated during
performance testing. Analyses revealed a significant Genotype x Trial interaction for
average speed, F(3.07, 52.22) = 4.92, p = .004, and maximum speed, F(4, 92) 5.46, p =
.001.. Wild-type mice ran at a faster average speed than Ppt1-/- mice during trials 1, 4,
and 5, p < .005, and also reached a faster maximum speed than Ppt1-/- mice during all
trials, p < .005. Within-groups, and unlike in previous weeks, neither group showed a
reliable increase in average speed or maximum speed from trial 1 to trial 5 (data not
shown). Multiple rmANOVAs revealed a main effect of Genotype on distance F(1, 23) =
36.92, p = .000, average speed F(1, 17) = 11.99, p = .003, maximum speed F(1, 23) =
25.11, p = .000, and time resting, F(1, 23) = 25.51, p = .000. WT mice traveled farther
(Figure 11F), ran at a higher average speed (Figure 12F), and reached a higher maximum
speed (Figure 13F) compared to mutants, and mutants rested for more time compared to

51

WTs (Figure 14F). As before, a main effect of Trial was found for distance F(3.16,
72.73) = 8.65, p = .000, average speed F(3.07, 52.22) = 10.29, p = .000, maximum speed
F(4, 92) = 7.64, p = .000, and time resting, F(2.01, 46.28) = 4.18, p = .021. All mice ran
farther during trials 2 and 3 compared to trial 4, p < .005, but no pairwise comparisons on
time resting remained significant following Bonferroni correction.
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Figure 11. Running wheel, total distance traveled. Juvenile WT mice ran significantly farther than Ppt1-/- mice during (A) baseline and (B)
acquisition running wheel testing. No effect of genotype was found on distance traveled during (C) performance testing. In the adult cohort, WT mice
ran farther than mutants over all three phases of testing (D, E, and F). * Denotes a significant main effect of Genotype, p <.05. ** Denotes a
significant main effect of Genotype, p = .000. ^ Denotes group differences at a single trial.
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Figure 12. Running wheel, average speed. WT and Ppt1-/- juvenile mice ran at similar average speeds during (A) baseline, (B) acquisition, and (C)
performance running wheel testing. In the adult cohort, WT mice ran faster, on average, than Ppt1-/- mice during (D) baseline, (E) acquisition, and (F)
performance testing.. * Denotes a significant main effect of Genotype, p < .05. ^ Denotes group differences at a single trial.
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Figure 13. Running wheel, maximum speed. Juveniles of both genotype attained similar maximum running speeds during (A) baseline, (B)
acquisition, and (C) performance testing. In the adult cohort, WT mice consistently reached higher maximum running speeds compared to Ppt1-/mice over (D) baseline, (E) acquisition, and (F) performance testing. * Denotes a significant main effect of Genotype, p ≤ .001. ^ Denotes group
differences at a single trial.
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Figure 14. Running wheel, time resting. Juvenile Ppt1-/- mice spent more time away from the wheel (resting) compared to WT mice during (A)
baseline and (B) acquisition testing. These groups did not differ during (C) performance testing. Adult Ppt1-/- mice spent more time away from the
wheel compared to WT mice over all 3 phases of running wheel testing (D, E, and F). * Denotes a significant main effect of Genotype, p ≤ .01. **
Denotes a significant main effect of Genotype, p = .000. ^ Denotes group differences at a single trial.

Conditioned Fear
For each min of a conditioned fear trial a percentage was recorded representing
the proportion of that min the animal spent freezing. Data for each of the 3 trials (toneshock training, contextual fear, and auditory cue) were analyzed with rmANOVAs with
Genotype (Ppt1-/- versus WT) as the main factor and Minute as the repeated measure.
For the tone-shock training and auditory cue trials, the first 2 min were analyzed apart
from subsequent min to assess baseline freezing behavior.
Juveniles. A rmANOVA revealed no effect of Genotype, Minute, or interaction
on baseline freezing behavior during tone-shock training. Analyses of subsequent min
revealed no significant interaction and no main effect of Genotype. However, a main
effect of Minute was revealed, F(1.63, 40.75) = 34.91, p = .000, indicating that all
animals increased freezing behavior from min 3 to min 5, p < .005 (Figure 15A).
Analyses revealed no significant effect of Genotype or Minute during contextual
fear trial (Figure 15B).
During the auditory cue trial, a main effect of Minute was discovered during the
first 2 min (baseline), F(1, 25) = 7.24, p = .013, revealing that all animals froze more
during min 2 than min 1. A rmANOVA over min 3-10 also revealed main effect of
Minute, F(3.36, 83.96) = 18.47, p = .000, but no effect of Genotype or any interaction
(Figure 15C). All animals froze more during min 3, 4, and 5 compared to min 8, 9, and
10, p < .001.
Adults. During the first 2 min of tone-shock training, a main effect of Genotype
was revealed for time spent freezing, F(1,23) = 5.49, p = .028, with Ppt1-/- mice freezing
significantly more than WT mice. During subsequent min, a main effect of Genotype was
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discovered, F(1,23) = 19.92, p = .000, as well as a main effect of Minute, F(2,46) =
55.79, p = .000, but no significant interaction was found. Ppt1-/- mice froze more than
WT mice overall and during min 3, p = .000, and min 5, p = .012. All mice froze
significant more during min 4 and 5 compared to min 3, p = .000, and during min 5
compared to min 3 and 4, p = .000 (Figure 15D).
Analyses revealed no effect of Genotype, nor a significant interaction effect, on
freezing behavior during the contextual fear test, but did reveal a significant effect of
Minute, F(3.44, 79.11) = 3.29, p = .020, with all animals freezing more during min 2 and
3 compared to min 1, p = .000 (Figure 15E).
Main effects of Genotype, F(1,23) = 11.96, p = .002, and Minute, F(1,23) =
17.08, p = .000 were found during the first 2 min of the auditory cue test. Analyses
revealed that Ppt1-/- mice froze more compared to WT mice overall and also during min
1, p = .003, and all animals froze more during min 2 compared to min 1. No interaction
effect was found on baseline freezing behavior. A rmANOVA over minutes 3 through 10
revealed a main effect of Genotype, F(1,23) = 28.07, p = .000, and Minute, F(5.60,
128.78) = 2.87, p = .014, as well as a significant Genotype x Minute interaction, F(5.60,
128.78) = 5.46, p = .000. WT mice froze significantly more than Ppt1-/- mice during min
3, 4, 5, and 6, p = .000. Within-groups, WT mice froze more during min 3 compared to
min 9 and 10, and during min 4 and 5 compared to min 9, p = .000 (Figure 15F).
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Figure 15. Conditioned fear. Ppt1-/- and WT juveniles performed similarly across all 3 days of conditioned fear testing, (A-C). There was no
effect of Genotype on baseline freezing behavior, fear conditioning to the T/S pairing, or contextual fear. In adults, on day 1, there was a main
effect of Genotype on baseline freezing behavior , with Ppt1-/- mice freezing more than WT mice, p = .028. Adult mice also showed a
significant increase in freezing behavior in response to the T/S pairing, but Ppt1-/- mice froze significantly more than WT mice, p = .000 (D).
Groups performed similarly as adults on day 2 (E). During the auditory cue test (F), Ppt1-/- mice froze more than WT mice during the first 2
min (baseline), p = .002. All mice exhibited increased freezing behavior in response to the CS (min 3-10), but WT mice froze significantly more
than Ppt1-/- mice, p = .000. * Denotes a significant main effect of Genotype. ^ Denotes group differences at a single minute.

Discussion
Infantile neuronal ceroid lipofuscinosis is a rare neurodegenerative disorder of
childhood that is devastating to those it afflicts. Underlying INCL is a mutation in the
Ppt1 gene. The result is a PPT enzyme deficiency which leads to the accumulation of
intracellular waste material. The Ppt1-/- mouse mimics this human condition in many
ways, including brain pathology, myoclonic seizures, and shortened life span. Little is
known about the behavior of this animal model.
The goal of the current study was to evaluate a breadth of behaviors in the Ppt1-/mouse model to further our understanding of INCL by providing useful behavioral
benchmarks of disease progression and treatment efficacy. The logic of the experiment
was to compare behaviors of juvenile Ppt1-/- mice, which have limited INCL-related
neuropathology, with adult Ppt1-/- mice, which have widespread and severe INCLrelated neuropathology. This was accomplished by examining performance of mutant and
WT strains at two ages, 1-2 months (referred to in this study as the “juvenile cohort”) and
5-6 months (“adult cohort”).
Results, overall, were that there were robust locomotor performance and gross
motor coordination differences between genotypes in adulthood, whereas juveniles
displayed more subtle differences, if any, in motor ability.
Experimental tests and hypotheses were based on previous literature indicating a
few behavioral deficits as well as the location and severity of disease pathology. Both
cohorts (juveniles and adults) were tested on the same battery of tests and in the same
order. Animals were first tested on the 1 h locomotor activity test with which differences
in activity levels were evaluated by quantifying vertical and horizontal movements in a

60

novel environment. Then mice were administered a battery of sensorimotor tasks to
measure strength, coordination, and balance. Spatial reference memory was evaluated
through the MWM, where a longer escape path length or latency indicated impaired
spatial memory acquisition during place trials. Platform crossings, time spent in the target
quadrant, and spatial bias were used to assess spatial memory retention. The rotarod test
followed as a measure of balance and fine motor coordination, and then the VOS test was
administered to evaluate visual acuity. One 20 min trial in the force plate actometer was
included as another measure of locomotor activity and to assess ambulatory-related
variables like stride length which may be associated with ataxia. The next test involved a
one-week exposure to a normal running wheel, followed by two consecutive weeks of
access to a custom, complex running wheel, which were used to evaluate general
ambulatory activity as well as fine motor coordination between hind- and fore-limbs.
Lastly, the conditioned fear procedure was conducted to assess Pavlovian conditioning
capabilities.
A sampling of the significant results revealed that Ppt1-/- mice during the juvenile
stage, and well before full adulthood, may experience sensorimotor deficits that affect
balance and/or coordination, and that it takes them numerous trials before they run the
same amount of time and distance as WT mice on the normal and complex running
wheels. Strangely, the Ppt1-/- mice in the juvenile cohort performed better on the visual
acuity test, compared to WT mice.
The two groups in the adult cohort exhibited robust differences across various
functions. The adult Ppt1-/- mice exhibited abnormal performance on all variables from
the 1 h locomotor activity test, and showed performance deficits on the ledge test, and
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took longer to learn to swim to the visible platform during the cued water maze trials.
The adult Ppt1-/- mice also demonstrated inferior performance on all variables of the
normal and complex activity wheels, and demonstrated impaired conditioning and/or
retention on the auditory cue component of the conditioned fear test.
The results of the 1 h locomotor activity test support my hypothesis that juvenile
groups would not differ on any variable, but that adult Ppt1-/- show performance deficits
on all of them. The current results also support previous findings on older animals. For
example, Griffey and colleagues (2006) reported that 7-month-old Ppt1-/- animals
exhibited reduced general exploratory behavior utilizing the same procedures that were as
used in the current experiment. Those 7-month-old Ppt1-/- mice also made fewer entries
into the central area of the activity chamber, suggesting increased anxiety-like behavior.
The same results were found in our 5-month-old mutants, which is not surprising given
the similarities in neuropathological indices between 5- and 7-month-old Ppt1-/- mice. It
is possible that this difference between Ppt1-/- and WT mice is due to disease-related
pathology. Kielar et al. (2007) described significant microglial activation at 5 months of
age in this animal model. Microglial activation is a reliable marker of neuroinflammation
and neurodegeneration, and Kielar et al. specifically noted this activation in S1, M1, and
various thalamic nuclei. With neuron loss in these loci accompanied by widespread
GROD accumulation, it is plausible that INCL neuropathology directly accounts for
decreased motor/sensorimotor capabilities or motivation to explore a novel environment.
The lower levels of activity in the older Ppt1-/- mice may also reflect a general malaise
caused by the disease, or a significant alteration in emotionality, e.g. increased anxiety-
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like behavior as suggested by these mice making fewer entries into, spending less time in,
and traveling a shorter distance in the center zone.
It is noteworthy in the current study that adult Ppt1-/- mice displayed deficits on
the ledge test of the sensorimotor battery. This is again consistent with the results of
Griffey et al. (2006) of 7-month-old mutants, although our older Ppt1-/- mice were not
impaired on the pole test whereas their mice were. Also of note were findings that both
the older and younger Ppt1-/- mice exhibited performance deficits on one of the screen
tests; juvenile Ppt-/- mice took longer than WT mice to climb to the top of the 60° screen,
while adult Ppt-/- mice showed a similar performance on the 90° screen. The impaired
inclined screen test performance of the Ppt1-/- groups is probably not due to diminished
strength since no differences were observed between groups on the inverted screen test at
either age. Instead, differences between groups on the inclined screen tests may reflect
slower movement or delays in initiation of movement on the part of the Ppt1-/- compared
to WT controls. However, it is not clear whether slower movement of the Ppt1-/- mice
reflects motor-sensorimotor disturbances, alterations in emotionality, or both.
The finding that juvenile Ppt-/- mice took longer than the WT mice to move out
of the square during the walking initiation test may be viewed as being consistent with
the inclined screen results. However, since the groups did not differ on the walking
initiation test as adults, it seems unlikely that the results from this test reflect a
meaningful difference related to disease progression. Some of the following discussion
concerning the impairment of the Ppt1-/- mice on other behavioral tests has relevance for
interpreting the possibly slowed movement of the INCL-model mice.
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There is little information in the literature documenting the cognitive abilities of
human patients with INCL. This surely is related to the early age of symptom onset and
rapid progression of the disease. There is a small window between birth and the advent of
symptoms. After onset, aggressiveness of the disease often results in the child living only
for a few years, during which time many functions have deteriorated due to progressive
neuropathology. It is simply not practical or even possible to test learning and memory on
such young children with already compromised brain function. It is not surprising, then,
that the learning capabilities of INCL patients are virtually unknown.
The Ppt1-/- mouse provides a unique window within which we assess changes in
learning, memory, and other cognitive domains. It was predicted that juvenile Ppt1-/mice would perform similarly to WTs regarding learning and memory functions since
only minor neuropathology was likely to be present at this age. In contrast, it was
expected that adult Ppt1-/- mice would exhibit impaired learning and memory functions
given the presence of significant GROD accumulation and astrocytosis in the brain, as
well as neuronal loss in the neocortex and hippocampus at this age.
The results from the juvenile water maze testing were consistent with the above
stated hypothesis. Specifically, no differences were observed between groups in terms of
escape path length or latency during the cued or place (spatial learning) trials. Retention
performance during the probe trial was also similar between groups with regard to all of
the relevant dependent variables. However, the Ppt1-/- mice swam more slowly than the
WT control group during the cued condition, although this did not seem to have a
significant impact on the path length and latency results. Moreover, the slower swimming
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speeds of the Ppt1-/- mice during the cued trials are consistent with the inclined screen
data describe above.
I also hypothesized that adult Ppt1-/- mice would display performance
impairment relative to WTs on all variables of the MWM because of likely accumulating
hippocampal pathology during full adulthood. The expected decrease in visual acuity and
impaired sensorimotor abilities would also predict poorer performance in the MWM
paradigm. The predicted visual deficit in these older animals was not found although this
result may be due to inadequate test sensitivity of the VOS procedure. The suggestion is
that the MWM results were free from this confound.
As was found with the younger animals, the adult Ppt1-/- mice swam more slowly
than the WT controls during the cued trials, but at this age the Ppt1-/- mice were also
found to be impaired in terms of escape path length and latency. Escape latency is
directly affected by swimming speeds so this measure is not a reliable index of
acquisition performance. In contrast, path length is probably minimally affected by
slower swimming speeds and thus longer path lengths of the Ppt1-/- mice suggest some
disturbance in cued learning. However, the nature of and mechanisms underlying the
cued learning deficit is not clear.
A remarkable finding form the water maze experiments in the present study is the
finding that adult Ppt1-/- and WT mice performed similarly on all place and probe
variables, including swim speeds after showing robust performance impairments during
the cued trials. This suggests that spatial learning and memory are intact in Ppt1-/- mice,
although it may be inferred from the cued trials data that cognitive functions related to
procedural memory may be compromised in these adult mutant mice and that these
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deficits may be overcome with increased practice. It should be noted that an extended
cued trials period was used in the present study in an effort to thoroughly assess the
possibility that visually-guided behaviors were compromised in the Ppt1-/- mice. The
extended training during the cued condition was likely important for providing adequate
practice and familiarity with the procedural aspects of the water of the water maze tank
such that the Ppt1-/- mice were able to perform normally during the subsequent place
trials.
Contrary to the hypothesis, genotype did not seem to affect performance on the
stationary, constant speed, or accelerating rotarod trials. No differences in performance
were observed between Ppt1-/- mice and the WT group in terms of their ability to remain
(balance) on the rod, whether stationary or rotating during either the juvenile or adult
testing.. The results from the juvenile cohort are similar to those found in a previous
study (Macauley et al., 2009) suggesting that at 1-month-old Ppt1-/- mice do not have
demonstrable performance deficits on the rotarod using standard protocols. However, it
was reported in the same study that 5-month-old Ppt1-/- mice performed significantly
worse on the constant speed (continuous) rotarod, compared to a WT group of the same
age, which is in contrast to our findings that there were no differences between the two
groups on any component of the rotarod procedure at 5 months of age, including the
accelerating rotarod.
There are major differences in the experimental design and rotarod protocols
between the present study and that of Macauley et al. that may account for the disparate
results between the two studies. First, the rotarod test was the only behavioral measure
used in the Macauley et al. study, whereas there were several tests in the present study
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that were conducted before the rotarod, and some involved relatively complex motorsensorimotor responding (e.g. sensorimotor battery, water maze). As discussed above, the
5-month-old Ppt1-/- mice in the present study exhibited fairly prominent sensorimotor
disturbances (e.g., decreased swimming speeds in the water maze), but this impaired
performance was resolved by continued swimming experience during testing such that
the Ppt1-/- mice eventually swam as fast as the WT group during the place trials. The
extensive handling of the mice in the current study also may have had a positive effect on
behavioral performance in general. In addition, there were important procedural
differences between the studies in that Macauley et al. evaluated their animals on 3 trials
(one stationary and two continuous) but only used the score on the final trial for analysis.
This is in contrast to the protocol used in the present study where mice were administered
2 constant speed and 2 accelerating rotarod trials on 3 separate days with all scores being
used for statistical analyses. Nevertheless, the general conclusion from both studies is that
Ppt1-/- mice have demonstrable motor/sensorimotor deficits at 5 months of age. In future
studies similar to the one presented here, replication of the rotarod using the currently
described protocol will help to solidify whether or not adult mutants show a deficit.
There is a consensus in the INCL literature that visual deficits progressing to
complete blindness are a reliable pattern of the disease, often occurring as the first
noticeable symptoms in patients (Griffey et al., 2005). Previous studies with the Ppt1-/mouse have revealed progressive retinal dysfunction beginning as early as 2 months of
age. One study in particular measured rod and cone function by electroretinography
(ERG) beginning at 1 month of age and retesting once a month through 7 months of age
(Griffey et al., 2005). Significant differences between mutants and WTs were found at 2

67

months for dark-adapted rod/cone ERGs, and 3 months for light-adapted ERGs. Retinal
function continued to worsen over months such that, by 7 months of age, Ppt1-/- mice
showed a 60% decrease in rod and cone function.
The hypothesis for the current experiment with the same animal model was that
adult, but not juvenile, Ppt1-/- mice would exhibit a decrease in visual acuity as measured
by the VOS test. However, the data from the present study do not support this. Present
results showed that no differences were observed between older Ppt1-/- mice and the WT
group in terms of visual acuity (grating) thresholds derived from the VOS measure,
suggesting that the Ppt1-/- mice were not impaired on this parameter. In addition, Ppt1-/mice showed a higher acuity threshold compared to the WT control group when tested on
the VOS when the mice were 1-month-old, which was also unexpected. It is unknown
how much of a decrease in ERG is required before it may be documented by a
behavioral test of visually-guided behavior. The results from the cued trials in the water
maze suggest the possibility of compromised visual function in the Ppt1-/- mice,
although they are clearly not blind since they are able to perform at control-like levels
during the place trials which implies that their vision may be good enough to use distal
cues to learn the location of the submerged platform. The pattern of the VOS results and
the suspiciously low thresholds found in the 5-month-old mice, along with the welldocumented neuropathology in the visual processing areas of the Ppt1-/- mouse brain
(Kielar et al., 2007; Shacka, 2012), lead us to suspect that our VOS data is unreliable.
Thus, further VOS testing is required in new cohorts of mice before we can draw any
conclusions about the degree to which visually-guided behavior is affected by
progressive visual system neuropathology in the Ppt1-/- mouse.
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It was hypothesized that juvenile Ppt1-/- and WT mice would perform similarly
with regard to distance traveled and the frequency of low mobility bouts during the 20
min actometer test session. However, Ppt1-/- animals traveled a significantly shorter
distance during the session than WTs, although the number of low mobility bouts was not
different between the two groups. It is not clear why the Ppt1-/- group traveled a shorter
distance in the actometer considering that the groups exhibited similar levels locomotor
activity (e.g., in distance traveled), during the preceding 1 h activity test. While the
number of low mobility bouts was similar between the two groups of mice, the distance
traveled when walking was greater in the WT group compared to the Ppt1-/- mice. It is
possible that shorter distance traveled by the Ppt1-/- group may reflect a subtle alteration
in stride length or rate potentially attributable to INCL neuropathology in relevant brain
regions. Indeed, while stride length was similar between genotypes at this age, stride rate
differed. WT mice had a faster stride rate compared to Ppt1-/- mice during the juvenile
stage. In this context the difference between genotypes in distance traveled becomes
clearer. WT mice take more strides per s than Ppt1-/- mice at this age. This early changes
in stride rate could be important in that it may presage the onset of motor-sensorimotor
disturbances. Alternatively, motivational factors may be responsible for the decreased
distance traveled by the Ppt1-/- mice.
Given that there is significant pathology in cerebellar white matter at 5 months of
age in Ppt1-/- mice, including heightened GROD accumulation in the thalamus and S1,
increased astrocytosis in S1 and M1, and microglial activation in M1, S1, and various
thalamic nuclei (Galvin et al., 2008; Kielar et al., 2007; Kielar et al., 2009), it was
expected that they would travel a shorter distance and exhibit increased low mobility
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bouts compared to WT mice. The data did not support this hypothesis in that there were
no differences between groups in either variable. It is interesting to note that although the
Ppt1-/- mice showed generally decreased ambulatory activity and rearing during the 1 h
locomotor activity test, differences were smallest during the first 20 min of the test, after
which differences became quite substantial. One possible explanation for the actometer
findings is that the session was only 20 m in length, and that the Ppt1-/- mice can match
the ambulatory levels of the WTs for a short duration like 20 min, but are unable to
sustain it over longer periods. Alternatively, the equivalent levels of locomotion in the
actometer may reflect similar responses to a novel environment which habituation and
allow for differences in activity to become apparent. The test chamber used for the 1 h
activity test is much more similar to the home cages of the mice compared to the
actometer, and thus the latter may have more salient novel features.
Another possible explanation comes from the measurement of individual stride
length and stride rate. While stride rate was similar between genotypes, stride length was
significantly different. WT mice took significantly longer strides when compared to Ppt1/- mice. At the juvenile stage, groups ran with a similar stride length, but WT mice took
faster individual strides. At the adult stage, groups ran at the same rate, but WT mice took
longer individual strides. It appears that there is a complex relationship between INCL
neuropathology and stride length and rate in this mouse model; juvenile Ppt1-/- mice
may experience disturbances in gross motor ability, while adult Ppt1-/- mice may show a
deficit in fine motor coordination between hind- and fore-limbs,
I hypothesized that there would be no differences between groups, during the
juvenile stage, on any of the variables during the normal (baseline) running wheel test.
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This was true for some variables but not others. For example, the juvenile Ppt1-/- mice
had similar average and maximum speeds compared to the WT group, although they ran
for shorter distances compared to the controls. Additionally, the Ppt1-/- mice spent more
time not running in the wheel compared to the WT group. Similar results were found in
the juvenile cohort during the complex wheel acquisition phase. While all animals tended
to increase their scores on variables associated with running over trials, the Ppt1-/- mice
traveled a significantly shorter distance compared to WT mice. It is possible that these
results stem from an overall inability of Ppt1-/- animals to match the stamina of WT
animals, even at a young age. Although the Ppt1-/- and WT groups show similar levels of
ambulatory/exploratory activity during the 1 h locomotor activity test, the running wheel
is a qualitatively different task that requires a higher level of coordination between foreand hind-limbs, particularly during the complex wheel trials. While the Ppt1-/- mice
show the ability to run as fast as the WT group, they may tire and/or become less
motivated more quickly. Similar to results from a previous study involving neonatal
dexamethasone treatment in mice when this same protocol was used, the results here
suggest that juvenile Ppt1-/- mice are capable of running at WT-like speeds, but that
subtle sensorimotor deficits may directly result in the mutants strain being unable to
maintain these speeds for long periods of time (Maloney et al., 2011). An alternative
explanation is that the running wheel was more difficult for Ppt1-/- mice and therefore
less reinforcing to them.
However, these differences between groups in the juvenile cohort disappeared
during the complex wheel performance trials: there was no main effect of genotype on
any variable, and all mice tended to increase performance over time. This result may be
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similar to the practice effect observed with regard to swimming speeds in the water maze
where swimming also involves complex coordination between fore- and hind-limbs. In
other words, continued practice on the normal activity wheel may have improved the
general coordination of the Ppt1-/- mice such that they were able to perform as well as
the WT control group during the complex wheel trials.
Results from the adult cohort showed a much more robust performance
impairment in the Ppt1-/- mice on the normal and complex running wheel trials, which
was observed across all variables and all trials. Not only did the Ppt1-/- mice travel a
shorter distance during all three phases, they also ran at slower average speeds and
reached slower maximum speeds compared to WT mice. These results partially support
my hypotheses; adult Ppt1-/- mice ran slower and a shorter distance than WT mice.
However, unlike my predictions, Ppt1-/- actually spent more time not running, indicating
either a loss of interest because of difficulty, or reflecting the lower levels of general
activity seen during the 1 h locomotor activity test. The aforementioned pathology
present in adult Ppt1-/- mice would seem to indicate both influences are possible: it is
likely that the Ppt1-/- mice were simply less active in general during running wheel trials,
but because of progressive neuropathology to M1, S1, and thalamus, even the normal
running wheel was likely more difficult for them than it was for WT mice.
The between-group differences found in the juvenile cohort during the baseline
and acquisition phases of running wheel testing were replicated in the adult cohort. It is
possible that the normal and complex running wheel protocol used in the current
experiment is sensitive enough to detect certain subtle sensorimotor disturbances in the
younger Ppt1-/- mice that are then exacerbated by older age and consequently appears
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more pervasive and are more easily detected. The consistent difference across ages for
total distance traveled, time spent running, and time spent resting during baseline and
acquisition is particularly notable because of disparate age-related results in other
behavioral tests used here. For instance, juvenile Ppt1-/- mice performed similar to WT
mice across all variables of the 1 h locomotor activity test, whereas adult Ppt1-/performed uniformly worse. In contrast, swim speeds during place and probe MWM
trials were similar between genotypes at both ages. Further, Ppt1-/- juveniles traveled a
shorter distance than WTs during the actometer test, whereas no difference between
genotypes was found in the adults. A complex profile of Ppt1-/- sensorimotor
impairment, across ages, becomes apparent when considering all of these results together.
The normal-complex activity wheel protocol may be sensitive enough to detect a deficit
in the Ppt1-/- mice at any age while other tests cannot. This has been found for other
mouse models of neurological disorders that include compromised sensorimotor function
(e.g. Liebetanz et al., 2007).
As was hypothesized, WT and Ppt1-/- juvenile mice performed similarly across
baseline and tone-shock training on day 1 as well as during contextual fear, and cued fear
trials. Both genotypes exhibited a significant response to the tone/shock pairing,
increasing freezing behavior over min 3, 4, and 5 during conditioning training. Groups
performed similarly on the contextual fear trial, suggesting similar levels of conditioning
to the contextual cues present during training in the absence of the tone-shock pairing.
Lastly, the Ppt1-/- and WT showed similar levels of freezing in response to the auditory
cue (CS) suggesting equivalent levels of conditioning or sensitization. This was

73

predicated as the result because of the lack of hippocampal-amygdalar pathology at this
age.
I hypothesized that widespread neuropathology in adult Ppt1-/- mice would
impair their ability to associate a conditioned stimulus (tone) or contextual cues with an
unconditioned stimulus (shock), thereby resulting in decreased freezing behavior in
mutants over all three trials. The data only partially supported this hypothesis; Ppt1-/adults in fact froze less in response to CS-exposure in a novel environment (cued fear).
Surprisingly, the Ppt1-/- mice showed an exaggerated freezing response to the initial
tone/shock pairing during fear conditioning training, compared to controls. This
exaggerated fear response is difficult to explain in light of their reduced cued fear
response during the third day, unless compromised auditory function affected cued
conditioning/sensitization. It is perhaps not surprising that the Ppt1-/- mice performed
similarly to the WT group during the contextual fear trial given that their spatial learning
and memory seems to be intact, as indicated by their performance on the MWM. The
conditioned fear results raise the possibility that some forms of conditioning or
conditioning-like processes may be disturbed in Ppt1-/- mice.
The current study has several notable limitations. First and foremost, it would be
ideal to include a third cohort with animals aged 3-4 months to better attain a complete
behavioral phenotype of the Ppt1-/-mouse. The current study provides previously
unavailable information on the behavior of this animal model of INCL during adulthood,
and also lays the groundwork for evaluating this mutant during younger ages to
appreciate just how early disease symptomology is detectable. Repeating the current
protocol on a group of animals aged 3-4 months would fill in the space between the
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cohorts presented here, thus helping to pinpoint the temporal presentation of symptoms
and potentially allowing for the comparison of symptom severity at various ages. One of
the greatest benefits of this study is that it establishes a more complete behavioral
phenotype of an established animal model of a rare human disorder, thus providing useful
benchmarks of disease progression and creating markers of specific symptoms by which
treatments can be evaluated. A third cohort would help to complete the picture regarding
the onset of each symptom.
Another consideration when interpreting the results of this study is that there was
an uneven distribution of sexes. In the juvenile cohort, only 10 of the 27 animals were
female. Within the females, the genotype distribution was 4 and 6. The adult cohort was
more evenly distributed, with females accounting for 12 of 25 animals, a distribution of 7
and 5. However, of the 13 males in the adult cohort, only 2 were WT. The most important
point concerning the unequal distributions of sexes in the current study was that it did not
allow for an evaluation of sex effects. At least one previous study in humans with another
subset of NCL, JNCL, has shown that females suffer from a more severe form of the
disease. Specifically, although females experienced the onset of symptoms approximately
1 year later than males, they died 1 year earlier and exhibited lower functional capability,
earlier loss of independent function, and lower physical quality of life (Cialone et al.,
2012). As such, follow-up studies would benefit from a more even distribution of genders
across genotypes in order to properly evaluate if males and females of this animal model
show a different onset, progression, or time-course of disease symptoms.
Future studies would also benefit from including immunohistopathology results in
order to confirm, at specific ages, exactly what INCL pathology is present. This would
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allow for the pairing of behavioral results at a specific time point to the matching
neuropathology present in the Ppt1-/- brain. It may also be worth considering testing
additional cohorts of Ppt1-/- mice on selected behavioral measures to determine the
reliability of the initial positive findings. The number of tests and test sequence may have
an impact on the behavioral results, and replications using independent cohorts may be
necessary to evaluate this possibility. Additionally, the current study employed a
behavioral battery that lasted approximately 39 days. It is established in the INCL
literature that pathology in specific brain areas can progress significantly over the period
of a month. The difference between a Ppt1-/-mouse at 1 month of age and 2 months of
age may be significant, depending on the measures being employed. Likewise, after 5
months of age certain functions deteriorate rapidly in Ppt1-/- mice, and a shorter, more
focused battery of behavioral tests would help to isolate deficits at more specific ages.
Conclusions
These findings confirm that the Ppt1-/- mouse is a useful animal model of INCL
and provide a broad characterization of the behavioral phenotype for this mutant strain
during the juvenile period and adulthood. Ppt1-/- mice display a complex profile of
cognitive and motor disabilities, including possible deficits in sensorimotor, locomotor,
and certain learning/memory functions that progressively deteriorate with age. The
results of the current study establish novel behavioral markers of the Ppt1-/- mouse
model of INCL that both clarify the phenotype of this mouse strain and also provide
useful benchmarks for evaluating treatment efficacy.
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